Through bioinformatic analysis and experiments, we discovered that SP1-activated lncRNA HIF1A-AS2 can accelerate CRC progression by promoting the mRNA level of FOXC1 (Fig. 10). Here, FOXC1 is linked to colorectal carcinoma.